BioSpace News Archive

Pharm Country

West Announces Three New Product Innovations at Pharmapack Europe

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced participation at Pharmapack Europe 2023 in Paris, France to showcase its leadership and expertise on industry challenges and trends in packaging and containment.

January 31, 2023
·
3 min read
FDA

Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Axonics, Inc. today announced that the U.S. Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation system.

January 31, 2023
·
3 min read
Business

Karuna Therapeutics Appoints William P. Kane as Chief Commercial Officer

Karuna Therapeutics, Inc. today announced the appointment of Will Kane as chief commercial officer (CCO), effective February 6, 2023.

January 31, 2023
·
3 min read
Business

Optinose Announces CEO Transition and Business Update

Optinose today announced that Peter Miller has stepped down as Chief Executive Officer and Board member, and that Ramy Mahmoud, MD, MPH has been appointed as Chief Executive Officer and Board member.

January 31, 2023
·
6 min read
Business

Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on Tuesday February 7, 2023Webcast and Conference Call To be Held Tuesday, February 7, 2023, 8:30 am ET

Anavex Life Sciences Corp. today announced that it will issue financial results for its quarter ended December 31, 2022 on Tuesday February 7, 2023.

January 31, 2023
·
3 min read
Business

Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers

Hillstream BioPharma, Inc. today announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein.

January 31, 2023
·
5 min read
Business

CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue

CytoSorbents Corporation issues a stockholder letter from its Chief Executive Officer, Dr. Phillip Chan, and announces preliminary unaudited fourth quarter 2022 and full year 2022 results ahead of filing its Form 10-K.

January 31, 2023
·
28 min read
Business

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on February 7, 2023

Deciphera Pharmaceuticals, Inc. today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, February 7, 2023.

January 31, 2023
·
1 min read
Business

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

Zhongchao Inc. today announced that that Chongqing Xinjiang Pharmaceutical Co., Ltd. obtained the general distribution rights in Mainland China for anti-influenza drug from Natco Pharma Limited (“Natco”).

January 31, 2023
·
5 min read
Business

Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program

Coeptis Therapeutics Holdings, Inc. today announced a sponsored research agreement with the University of Pittsburgh to advance pre-clinical development of SNAP-CAR T cells targeting HER2 as well as identify opportunities to expand the applicability of SNAP-CAR in oncology.

January 31, 2023
·
7 min read